Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Posted on 08/03/2025 by sciencefather

Dr. Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Dr. Soumya Basu, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, India.

Dr. Soumya Basu is a distinguished scientist and academic specializing in cancer and translational research. With a Ph.D. in Life Sciences and over 18 years of research experience, he has made significant contributions to understanding drug-resistant cancer and targeted therapies. His academic journey spans multiple disciplines, including microbiology, medical writing, and artificial intelligence applications in cancer research. As an Associate Professor at Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, he has played a pivotal role in scientific mentorship, research advancements, and cross-disciplinary collaborations. His expertise in molecular oncology, cell-based assays, and small molecule design has led to impactful research, widely recognized in the scientific community through publications and citations.

Profile

Google Scholar

Early Academic Pursuits 🎓

From an early stage, Dr. Soumya Basu exhibited a keen interest in the sciences, embarking on an academic journey that laid the foundation for an illustrious career in life sciences and cancer research. He earned a Bachelor of Science in Physics, Chemistry, and Mathematics from the University of Burdwan, followed by a Master’s degree in Microbiology from the University of Kalyani. His unwavering passion for research led him to pursue a Ph.D. in Life Sciences at Jadavpur University, focusing on reactive oxygen species-mediated targeted therapy in drug-resistant cancer. Further enhancing his expertise, he pursued an Advanced Diploma in Medical Writing and Regulatory Affairs and later completed an Advanced Postgraduate course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, reinforcing his multidisciplinary approach to modern scientific research.

Professional Endeavors 🎮

Dr. Basu’s professional journey is marked by his dedication to academia and translational research. He currently serves as an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Pune. His tenure at Dr. D. Y. Patil Vidyapeeth spans over a decade, where he initially joined as an Assistant Professor before rising to his current role. Prior to this, he contributed significantly as a Research Associate at the Molecular Functional Imaging Laboratory, ACTREC, Tata Memorial Center, and held esteemed positions as a Senior Research Fellow at the Chittaranjan National Cancer Institute (CNCI) and a Project Assistant at Jadavpur University and the University of Calcutta. His early teaching career at Kulti College further highlights his commitment to education and mentorship.

Contributions and Research Focus 🧑‍�‍🔬

Dr. Basu’s research is deeply rooted in cancer therapeutics, particularly in drug-resistant malignancies. His work spans multiple domains, including animal cell culture, cell-based assays, small molecule design and validation, and non-coding RNA research. With a strong emphasis on translational research, he has been at the forefront of developing novel therapeutic strategies targeting drug-resistant cancer cells. His contributions to molecular oncology and biotechnology have paved the way for advancements in personalized medicine, integrating computational approaches like artificial intelligence and machine learning to enhance predictive models in cancer treatment.

Accolades and Recognition 🏆

Over his distinguished career, Dr. Basu has garnered widespread recognition for his contributions to scientific research. His prolific publication record, including books, book chapters, research articles, and technical reports, attests to his commitment to advancing knowledge in cancer biology. His Google Scholar profile boasts an H-index of 14, with over 550 citations, underscoring the impact of his research in the global scientific community. His expertise in scientific writing and editing has also made him a sought-after mentor and collaborator in academia.

Impact and Influence 📈

Dr. Basu’s work has had a profound impact on the field of oncology, with his research findings influencing therapeutic strategies and treatment paradigms. His mentorship and guidance have inspired numerous young researchers, fostering the next generation of scientists dedicated to battling cancer. His contributions extend beyond the laboratory, as he actively participates in knowledge dissemination through conferences, workshops, and academic collaborations. His ability to bridge the gap between fundamental research and clinical application has positioned him as a thought leader in the field.

Legacy and Future Contributions 🌟

As a scientist and educator, Dr. Basu’s legacy is defined by his relentless pursuit of innovation in cancer research. His ongoing work aims to refine targeted therapies, explore novel drug delivery systems, and harness artificial intelligence for more effective cancer diagnostics and treatment. With a vision to create a lasting impact on cancer care, he continues to drive transformative research initiatives. His unwavering commitment to scientific excellence ensures that his contributions will shape the future of oncology for years to come.

Publication

Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine
- Authors: B Chattopadhyay, S Basu, P Chakraborty, SK Choudhuri, AK Mukherjee, …
- Year: 2009

Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate
- Authors: A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, …
- Year: 2010

Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach
- Authors: KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu
- Year: 2022

Use of BRET to study protein–protein interactions in vitro and in vivo
- Authors: S Dimri, S Basu, A De
- Year: 2016

Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis
- Authors: A Ganguly, S Basu, K Banerjee, P Chakraborty, A Sarkar, M Chatterjee, …
- Year: 2011

PPAR-γ partial agonists in disease-fate decision with special reference to cancer
- Authors: S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu
- Year: 2022

Drug repurposing—an emerging strategy in cancer therapeutics
- Authors: JA Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, S Basu
- Year: 2022

Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule study
- Authors: KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu
- Year: 2020

Conclusion 🌟

Dr. Soumya Basu’s career is a testament to his unwavering dedication to cancer research and academia. His contributions to targeted therapies, translational oncology, and biomedical advancements continue to influence both scientific understanding and clinical applications. Through his mentorship and research initiatives, he is shaping the next generation of scientists while driving forward innovative solutions for cancer treatment. With his ongoing efforts in integrating AI with biomedical sciences, Dr. Basu remains at the forefront of cutting-edge cancer research, ensuring a lasting impact on the field.

Vikash Kumar | Molecular Biology | Best Researcher Award

Posted on 05/03/202507/03/2025 by sciencefather

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute, India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
Year: 2019

Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
Authors: V Kumar, S Roy, DK Meena, UK Sarkar
Year: 2016

Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
Year: 2021

Immunostimulants for Aquaculture Health Management
Authors: D Barman, P Nen, SC Mandal, V Kumar
Year: 2013

A Practical Approach on SDS PAGE for Separation of Protein
Authors: S Roy, V Kumar
Year: 2014

Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
Year: 2018

Biofloc Microbiome with Bioremediation and Health Benefits
Authors: V Kumar, S Roy, BK Behera, BK Das
Year: 2021

Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
Authors: S Roy, V Kumar, V Kumar, BK Behera
Year: 2017

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Dinh Phong Son | CircRNA | Best Researcher Award

Posted on 19/02/2025 by sciencefather

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

Publication

Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
Year: 2025

Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
Year: 2024

Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
Authors: ChauMyThanh Tran, PhongSon Dinh
Year: 2024

Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
Year: 2023

Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
Year: 2022

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Posted on 17/02/202517/02/2025 by sciencefather

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

Publication

Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
Year: 2025

The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
Year: 2023

Nonviral delivery systems for antisense oligonucleotide therapeutics
Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
Year: 2022

The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
Year: 2022

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Authors: Not explicitly listed
Year: 2021

Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
Year: 2021

Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
Year: 2020

Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
Authors: Not explicitly listed
Year: 2019

Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
Year: 2019

Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
Authors: Not explicitly listed
Year: 2018

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

Kawthar Diab | Life Science | Best Researcher Award

Posted on 10/02/2025 by sciencefather

Kawthar Diab | Life Science | Best Researcher Award

Prof. Dr. Kawthar Diab, National Research Centre, Egypt.

Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a distinguished Research Professor in Genetics and Cytology at the National Research Centre, Cairo, Egypt. With a strong foundation in zoology, she pursued advanced degrees focusing on genotoxicity, cytogenetics, and medicinal plant applications in disease prevention. Her postdoctoral research at Tokai University, Japan, and the Indian Institute of Integrative Medicine, India, expanded her expertise in cancer pharmacology and bioscience. Dr. Diab has made significant contributions to genetic toxicology and the chemopreventive properties of medicinal plants, with a particular focus on the Lamiaceae family and Himalayan plants. She actively mentors Ph.D. students and collaborates on groundbreaking research projects, gaining international recognition through conferences and workshops.

Profile

Google Scholar

Scopus

🌱 Early Academic Pursuits

Kawthar Abdelaziz Elsayed Mohamed Diab embarked on her academic journey with a deep passion for zoology, earning her B.Sc. in Zoology from Al-Azhar University in 1996 with a distinguished grade of “Very Good.” She further honed her expertise by obtaining an M.Sc. in Experimental Zoology from Zagazig University in 2003, where she conducted cytogenetic and immunogenetic studies on the effects of chemotherapy drugs on reproduction. Her academic curiosity and dedication led her to pursue a Ph.D. in Zoology at Ain Shams University, awarded in 2009. Her doctoral research focused on the protective effects of medicinal plants against genotoxic damage induced by hydrocortisone in mice, marking the beginning of her lifelong commitment to genetic research and cytology.

🧬 Professional Endeavors

As a Research Professor at the Genetics and Cytology Department of the National Research Centre in Cairo, Egypt, Dr. Kawthar Diab has played a pivotal role in advancing genetic studies. Her postdoctoral fellowships further expanded her scientific horizons—first in Cancer Pharmacology at the Indian Institute of Integrative Medicine in 2012 and later in Bioscience at Tokai University, Japan, in 2014. These international research experiences enriched her expertise in genetic applications, cytogenetics, and pharmacogenomics. Her relentless pursuit of knowledge has positioned her as a leading researcher in genetic and cytological studies, bridging traditional knowledge with cutting-edge scientific advancements.

🌿 Contributions and Research Focus

Dr. Diab’s research delves into the genotoxicity of pharmaceutical compounds and the protective effects of medicinal plants. Her investigations focus on the genetic impact of chemotherapy drugs and natural therapeutic agents, particularly those derived from the Lamiaceae family, known for their biochemical and therapeutic properties. Her recent supervision of Ph.D. research on biochemical and therapeutic evaluations of medicinal plants for prostate diseases underscores her commitment to integrating molecular genetics with natural medicine. Additionally, her work on cancer chemoprevention using Himalayan plants has gained international recognition, reflecting her dedication to discovering novel plant-based remedies for serious health conditions.

🌍 Accolades and Recognition

Dr. Kawthar Diab’s expertise has been acknowledged on the global stage. She was invited as a speaker at the 6th Rajabhat University National and International Research and Academic Conference (2020), where she presented her groundbreaking research on cancer chemopreventive activity of Himalayan plants. She has also participated in esteemed international workshops, including the Fluorescence Microscopy Workshop at ICGEB, New Delhi (2019), further enhancing her methodological skills. These recognitions highlight her contributions to genetic research and her growing influence in the scientific community.

📖 Impact and Influence

Beyond her research, Dr. Diab is actively shaping the next generation of scientists. She mentors young researchers, including Ph.D. students working on innovative projects in pharmacogenomics and plant-based medicine. Her collaboration with interdisciplinary teams ensures that her work extends beyond academic publications, making real-world contributions to medical science and genetics. By fostering a culture of inquiry and scientific exploration, she continues to inspire budding researchers to explore the genetic foundations of disease prevention and treatment.

🔬 Legacy and Future Contributions

With a research portfolio spanning genetic toxicology, medicinal plant applications, and cytogenetics, Dr. Kawthar Diab’s legacy is firmly established in the scientific world. She envisions a future where genetic research and plant-based therapeutics converge to provide safer, more effective treatments for cancer and genetic disorders. Her continuous engagement with international scientific platforms and her mentorship of emerging scholars ensure that her influence will extend far beyond her own research, shaping the future of genetic and cytological studies.

Publication

Title: In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleifera Indian Plants
Author: KAE Diab, SK Guru, S Bhushan, AK Saxena
Year: 2015

Title: In vitro studies on phytochemical content, antioxidant, anticancer, immunomodulatory, and antigenotoxic activities of lemon, grapefruit, and mandarin citrus peels
Author: KAE Diab
Year: 2016

Title: In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-Nitroso-N-methylurea in mice
Author: KA Diab, EI Aboul-Ela
Year: 2012

Title: Carbon tetrachloride induced hepato/renal toxicity in experimental mice: antioxidant potential of Egyptian Salvia officinalis L essential oil
Author: MA Fahmy, KA Diab, NS Abdel-Samie, EA Omara, ZM Hassan
Year: 2018

Title: Genotoxicity of carbon tetrachloride and the protective role of essential oil of Salvia officinalis L. in mice using chromosomal aberration, micronuclei formation, and …
Author: KAE Diab, MA Fahmy, ZM Hassan, EM Hassan, AB Salama, EA Omara
Year: 2018

Title: Inhibitory activity of black mulberry (Morus nigra) extract against testicular, liver and kidney toxicity induced by paracetamol in mice
Author: KA Diab, MA Fahmy, EM Hassan, ZM Hassan, EA Omara, …
Year: 2020

Title: The impact of the low frequency of the electromagnetic field on human
Author: KA Diab
Year: 2020

Title: Inhibitory activity of flaxseed oil against CdCl2 induced liver and kidney damage: Histopathology, genotoxicity, and gene expression study
Author: KA Diab, NE Ibrahim, MA Fahmy, EM Hassan, EA Omara
Year: 2020

🏆 Conclusion

Dr. Kawthar Diab’s journey from an aspiring zoologist to a distinguished Research Professor in Genetics and Cytology is a testament to her unwavering commitment to scientific discovery. Her work not only enhances our understanding of genetic toxicology but also paves the way for integrating traditional medicinal knowledge with modern genetic research. As she continues to push the boundaries of genetic science, her contributions remain invaluable to both academia and global health advancements.